Milosz Gruca
Corporate Officer/Principal at SELVITA S.A.
Net worth: 1 M $ as of 31/03/2024
Profile
Milosz Gruca is currently a Member of the Management Board at BioCentrum Sp zoo and the Chief Commercial Officer & Executive VP at Selvita SA. Previously, he served as a Member of the Management Board at Ryvu Therapeutics SA from 2007 to 2014.
Dr. Gruca holds a graduate and doctorate degree from Uniwersytet Jagiellonski, an MBA from Cracow University of Economics, and another MBA from Stockholm Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SELVITA SA
0.33% | 08/11/2022 | 60,760 ( 0.33% ) | 1 M $ | 31/03/2024 |
Milosz Gruca active positions
| Companies | Position | Start |
|---|---|---|
| SELVITA S.A. | Corporate Officer/Principal | 01/01/2007 |
BioCentrum Sp zoo
 BioCentrum Sp zoo Miscellaneous Commercial ServicesCommercial Services BioCentrum Sp zoo is a biotechnology company, which engages in the provision of preclinical development services and products. It also offers absorption, distribution, metabolism, and excretion testing; and behavioural studies. The company was founded in 2004 and is headquartered in Krakow, Poland. | Corporate Officer/Principal | - |
Former positions of Milosz Gruca
| Companies | Position | End |
|---|---|---|
| RYVU THERAPEUTICS S.A. | Corporate Officer/Principal | - |
Training of Milosz Gruca
| Uniwersytet Jagiellonski | Doctorate Degree |
| Cracow University of Economics | Masters Business Admin |
| Stockholm Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| RYVU THERAPEUTICS S.A. | Health Technology |
| SELVITA S.A. | Health Technology |
| Private companies | 1 |
|---|---|
BioCentrum Sp zoo
BioCentrum Sp zoo Miscellaneous Commercial ServicesCommercial Services BioCentrum Sp zoo is a biotechnology company, which engages in the provision of preclinical development services and products. It also offers absorption, distribution, metabolism, and excretion testing; and behavioural studies. The company was founded in 2004 and is headquartered in Krakow, Poland. | Commercial Services |
- Stock Market
- Insiders
- Milosz Gruca
